HLFMX
Price
$9.59
Change
-$0.04 (-0.42%)
Updated
Sep 11 closing price
Net Assets
121.26M
RNWHX
Price
$107.05
Change
-$0.71 (-0.66%)
Updated
Sep 11 closing price
Net Assets
90.01B
Interact to see
Advertisement

HLFMX vs RNWHX

HLFMX vs RNWHX Comparison Chart in %
View a ticker or compare two or three
VS
HLFMX vs. RNWHX commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HLFMX is a StrongBuy and RNWHX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNWHX has more cash in the bank: 90B vs. HLFMX (121M). HLFMX pays higher dividends than RNWHX: HLFMX (3.33) vs RNWHX (1.15). HLFMX was incepted earlier than RNWHX: HLFMX (18 years) vs RNWHX (11 years). HLFMX (1.42) is less costly to investors than RNWHX (0.72). RNWHX is a more actively managed with annual turnover of: 46.00 vs. HLFMX (29.00). RNWHX has a lower initial minimum investment than HLFMX: RNWHX (250) vs HLFMX (100000). RNWHX annual gain was more profitable for investors over the last year : 17.19 vs. HLFMX (9.03). HLFMX return over 5 years is better than : 19.11 vs. RNWHX (17.68).
HLFMXRNWHXHLFMX / RNWHX
Total Expense Ratio1.420.72197%
Annual Report Gross Expense Ratio1.420.72197%
Fund Existence18 years11 years-
Gain YTD7.72716.44747%
Front LoadN/AN/A-
Min. Initial Investment10000025040,000%
Min. Initial Investment IRAN/AN/A-
Net Assets121M90B0%
Annual Yield % from dividends3.331.15290%
Returns for 1 year9.0317.1953%
Returns for 3 years42.1753.8478%
Returns for 5 years19.1117.68108%
Returns for 10 years52.61111.4447%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FLPEX46.310.28
+0.61%
Fidelity Advisor Low-Priced Stock C
FACDX64.25N/A
N/A
Fidelity Advisor Health Care A
EXHAX26.61N/A
N/A
Manning & Napier Pro-Blend Max Term S
LMCFX35.98N/A
N/A
Lord Abbett Mid Cap Stock F
MSAWX22.51N/A
N/A
Morgan Stanley Inst Asia Opp C